Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 30, 2015
Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?
L Apetoh, S Ladoire, G Coukos, et al.
Current Molecular Medicine
|
May 17, 2011
Restoration of antitumor immunity through selective inhibition of myeloid derived suppressor cells by anticancer therapies
L Apetoh, F Végran, S Ladoire, et al.
Oncogene
|
May 26, 2010
Human FOXP3 and cancer
F Martin, S Ladoire, G Mignot, et al.
Cell Death and Differentiation
|
November 17, 2007
Molecular characteristics of immunogenic cancer cell death
A Tesniere, T Panaretakis, O Kepp, et al.
British Journal of Cancer
|
July 14, 2011
T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survival
S Ladoire, L Arnould, G Mignot, et al.
Oncogene
|
February 9, 2016
Inhibition of colon cancer growth by docosahexaenoic acid involves autocrine production of TNFα
A Fluckiger, A Dumont, V Derangère, et al.
Cytokine & Growth Factor Reviews
|
October 15, 2017
Innovative Therapy, Monoclonal Antibodies and Beyond
M Di Nicola, L Apetoh, M Bellone, et al.
Cell Death and Differentiation
|
August 16, 2014
Liver X receptor β activation induces pyroptosis of human and murine colon cancer cells
V Derangère, A Chevriaux, F Courtaut, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 21, 2012
FOXP3 expression in cancer cells and anthracyclines efficacy in patients with primary breast cancer treated with adjuvant chemotherapy in the phase III UNICANCER-PACS 01 trial
S Ladoire, G Mignot, C Dalban, et al.
Oncogene
|
November 3, 2009
Immunogenic death of colon cancer cells treated with oxaliplatin
A Tesniere, F Schlemmer, V Boige, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 30, 2015
Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?
L Apetoh, S Ladoire, G Coukos, et al.
Current Molecular Medicine
|
May 17, 2011
Restoration of antitumor immunity through selective inhibition of myeloid derived suppressor cells by anticancer therapies
L Apetoh, F Végran, S Ladoire, et al.
Oncogene
|
May 26, 2010
Human FOXP3 and cancer
F Martin, S Ladoire, G Mignot, et al.
Cell Death and Differentiation
|
November 17, 2007
Molecular characteristics of immunogenic cancer cell death
A Tesniere, T Panaretakis, O Kepp, et al.
British Journal of Cancer
|
July 14, 2011
T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survival
S Ladoire, L Arnould, G Mignot, et al.
Oncogene
|
February 9, 2016
Inhibition of colon cancer growth by docosahexaenoic acid involves autocrine production of TNFα
A Fluckiger, A Dumont, V Derangère, et al.
Cytokine & Growth Factor Reviews
|
October 15, 2017
Innovative Therapy, Monoclonal Antibodies and Beyond
M Di Nicola, L Apetoh, M Bellone, et al.
Cell Death and Differentiation
|
August 16, 2014
Liver X receptor β activation induces pyroptosis of human and murine colon cancer cells
V Derangère, A Chevriaux, F Courtaut, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 21, 2012
FOXP3 expression in cancer cells and anthracyclines efficacy in patients with primary breast cancer treated with adjuvant chemotherapy in the phase III UNICANCER-PACS 01 trial
S Ladoire, G Mignot, C Dalban, et al.
Oncogene
|
November 3, 2009
Immunogenic death of colon cancer cells treated with oxaliplatin
A Tesniere, F Schlemmer, V Boige, et al.
Page
of 1